CORD-19:c654596857bce9cdd64ffc51842048643107348c / 81486-81715 JSONTXT

Annnotations TAB JSON ListView MergeView

    CORD-19-Sentences

    {"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T661","span":{"begin":0,"end":12},"obj":"Sentence"},{"id":"TextSentencer_T662","span":{"begin":13,"end":229},"obj":"Sentence"},{"id":"T56040","span":{"begin":0,"end":12},"obj":"Sentence"},{"id":"T36144","span":{"begin":13,"end":229},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Conclusions: Treatment of infections with emerging agents in immunocompromised patients is difficult, guidance by results of susceptibility testing being misleading with a poor correlation between the tests and treatment outcome."}

    Epistemic_Statements

    {"project":"Epistemic_Statements","denotations":[{"id":"T123","span":{"begin":0,"end":229},"obj":"Epistemic_statement"}],"text":"Conclusions: Treatment of infections with emerging agents in immunocompromised patients is difficult, guidance by results of susceptibility testing being misleading with a poor correlation between the tests and treatment outcome."}

    CORD-19_Custom_license_subset

    {"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T257","span":{"begin":0,"end":12},"obj":"Sentence"},{"id":"T258","span":{"begin":13,"end":229},"obj":"Sentence"}],"text":"Conclusions: Treatment of infections with emerging agents in immunocompromised patients is difficult, guidance by results of susceptibility testing being misleading with a poor correlation between the tests and treatment outcome."}

    CORD-19-PD-MONDO

    {"project":"CORD-19-PD-MONDO","denotations":[{"id":"T309","span":{"begin":26,"end":36},"obj":"Disease"},{"id":"T61922","span":{"begin":26,"end":36},"obj":"Disease"}],"attributes":[{"id":"A309","pred":"mondo_id","subj":"T309","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A67194","pred":"mondo_id","subj":"T61922","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"Conclusions: Treatment of infections with emerging agents in immunocompromised patients is difficult, guidance by results of susceptibility testing being misleading with a poor correlation between the tests and treatment outcome."}